PET measurement of neuroreceptor occupancy by typical and atypical neuroleptics. 1996

P F Goyer, and M S Berridge, and E D Morris, and W E Semple, and B A Compton-Toth, and S C Schulz, and D F Wong, and F Miraldi, and H Y Meltzer
Cleveland Veterans Affairs Medical Center, Ohio 44141, USA.

The goal of this study was to use PET and 11C-N-methylspiperone (11C-NMSP) to measure the difference in relative occupancy of serotonin (5-hydroxytryptamine-2 or 5-HT2A) and dopamine-2 (D2) neuroreceptors in subjects being treated with typical or atypical antipsychotic drugs. METHODS We used PET and single-dose 11C-NMSP to measure receptor indices and relative receptor occupancy of 5-HT2A receptors in frontal cortex and D2 receptors in basal ganglia in five subjects who were neuroleptic free, five subjects who were being treated with typical antipsychotic drugs and five subjects who were being treated with clozapine, an atypical antipsychotic drug. RESULTS Among the three groups, there were significant differences in 5-HT2A indices, D2 indices and the ratio of 5-HT2A to D2 indices. With no overlap, the 5-HT2A index separated all subjects who received clozapine and the D2 index separated the remaining two groups. CONCLUSIONS Typical antipsychotic and atypical antipsychotic subjects do have differing patterns of 5-HT2A and D2 relative receptor occupancy when measured with a single PET scan, single 11C-NMSP radiotracer dose and no separately injected "cold" pharmaceutical.

UI MeSH Term Description Entries
D008297 Male Males
D011985 Receptors, Serotonin Cell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action. 5-HT Receptor,5-HT Receptors,5-Hydroxytryptamine Receptor,5-Hydroxytryptamine Receptors,Receptors, Tryptamine,Serotonin Receptor,Serotonin Receptors,Tryptamine Receptor,Tryptamine Receptors,Receptors, 5-HT,Receptors, 5-Hydroxytryptamine,5 HT Receptor,5 HT Receptors,5 Hydroxytryptamine Receptor,5 Hydroxytryptamine Receptors,Receptor, 5-HT,Receptor, 5-Hydroxytryptamine,Receptor, Serotonin,Receptor, Tryptamine,Receptors, 5 HT,Receptors, 5 Hydroxytryptamine
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D003024 Clozapine A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. Clozaril,Leponex
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001479 Basal Ganglia Large subcortical nuclear masses derived from the telencephalon and located in the basal regions of the cerebral hemispheres. Basal Nuclei,Ganglia, Basal,Basal Nuclear Complex,Ganglion, Basal,Basal Nuclear Complices,Nuclear Complex, Basal,Nuclei, Basal
D001714 Bipolar Disorder A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence. Affective Psychosis, Bipolar,Bipolar Disorder Type 1,Bipolar Disorder Type 2,Bipolar Mood Disorder,Depression, Bipolar,Manic Depression,Manic Disorder,Manic-Depressive Psychosis,Psychosis, Manic-Depressive,Type 1 Bipolar Disorder,Type 2 Bipolar Disorder,Psychoses, Manic-Depressive,Bipolar Affective Psychosis,Bipolar Depression,Bipolar Disorders,Bipolar Mood Disorders,Depression, Manic,Depressions, Manic,Disorder, Bipolar,Disorder, Bipolar Mood,Disorder, Manic,Manic Depressive Psychosis,Manic Disorders,Mood Disorder, Bipolar,Psychoses, Bipolar Affective,Psychoses, Manic Depressive,Psychosis, Bipolar Affective,Psychosis, Manic Depressive

Related Publications

P F Goyer, and M S Berridge, and E D Morris, and W E Semple, and B A Compton-Toth, and S C Schulz, and D F Wong, and F Miraldi, and H Y Meltzer
November 1994, Biological psychiatry,
P F Goyer, and M S Berridge, and E D Morris, and W E Semple, and B A Compton-Toth, and S C Schulz, and D F Wong, and F Miraldi, and H Y Meltzer
January 2011, Handbook of clinical neurology,
P F Goyer, and M S Berridge, and E D Morris, and W E Semple, and B A Compton-Toth, and S C Schulz, and D F Wong, and F Miraldi, and H Y Meltzer
January 1987, Psychopharmacology bulletin,
P F Goyer, and M S Berridge, and E D Morris, and W E Semple, and B A Compton-Toth, and S C Schulz, and D F Wong, and F Miraldi, and H Y Meltzer
May 1979, Neuropharmacology,
P F Goyer, and M S Berridge, and E D Morris, and W E Semple, and B A Compton-Toth, and S C Schulz, and D F Wong, and F Miraldi, and H Y Meltzer
February 1992, Lancet (London, England),
P F Goyer, and M S Berridge, and E D Morris, and W E Semple, and B A Compton-Toth, and S C Schulz, and D F Wong, and F Miraldi, and H Y Meltzer
October 2001, The American journal of psychiatry,
P F Goyer, and M S Berridge, and E D Morris, and W E Semple, and B A Compton-Toth, and S C Schulz, and D F Wong, and F Miraldi, and H Y Meltzer
May 1999, Biulleten' eksperimental'noi biologii i meditsiny,
P F Goyer, and M S Berridge, and E D Morris, and W E Semple, and B A Compton-Toth, and S C Schulz, and D F Wong, and F Miraldi, and H Y Meltzer
January 1991, Psychopharmacology bulletin,
P F Goyer, and M S Berridge, and E D Morris, and W E Semple, and B A Compton-Toth, and S C Schulz, and D F Wong, and F Miraldi, and H Y Meltzer
January 1996, Biological psychiatry,
P F Goyer, and M S Berridge, and E D Morris, and W E Semple, and B A Compton-Toth, and S C Schulz, and D F Wong, and F Miraldi, and H Y Meltzer
October 1986, Naunyn-Schmiedeberg's archives of pharmacology,
Copied contents to your clipboard!